XBI ETF (State Street SPDR S&P Biotech ETF) is managed by State Street Investment Management with $8.10B in net assets. XBI expense ratio is 0.35%, holding 155 positions across sectors including Health Care, Unknown, Other. Inception date: 2006-01-31.

XBI performance shows a YTD return of 4.82%. The 1-year return is 44.10% and the 5-year return is -2.83%. XBI dividend yield stands at 0.35%, paid quarterly.

XBI top holdings include Moderna therapeutics (1.8%), Vaxcyte Inc (1.6%), Mirum Pharmaceuticals Inc (1.6%), Revolution Medicines Inc Ser C Pc Pp (1.5%), Alkermes Plc (1.5%). View all XBI holdings, sector breakdown, or dividend history.

XBI can be compared against other funds using the overlap calculator or side-by-side comparison tool. XBI alternatives are available via the screener, along with tax-loss harvesting opportunities.